![Michael Sumner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Sumner
Chief Tech/Sci/R&D Officer at
INOVIO PHARMACEUTICALS, INC.
Net worth: 46 242 $ as of 30/06/2026
Profile
Michael Sumner is currently Chief Medical Officer & Head-Development at Inovio Pharmaceuticals, Inc. since 2022 and a Member of The Royal College of Physicians.
Former roles include Senior Director-Medical Affairs at Aventis Behring, Executive Director-Medical Affairs at Novo Nordisk Pharmaceuticals Pty Ltd., Vice President-Clinical & Medical Affairs at Shire Regenerative Medicine, Inc., Medical Manager at Novartis Pharmaceuticals UK Ltd., and Chief Medical Officer at Orexo AB from 2013 to 2022.
Education includes a doctorate from the University of London and an MBA from Henley Management College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 20/05/2026 | 42,038 ( 0.05% ) | 46 242 $ | 30/06/2026 |
Michael Sumner active positions
| Companies | Position | Start |
|---|---|---|
| INOVIO PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 27/06/2022 |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Former positions of Michael Sumner
| Companies | Position | End |
|---|---|---|
| OREXO AB | Chief Tech/Sci/R&D Officer | 26/10/2022 |
Shire Regenerative Medicine, Inc.
 Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Manufactures biomedical products | Chief Tech/Sci/R&D Officer | - |
Novo Nordisk Pharmaceuticals Pty Ltd.
 Novo Nordisk Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for diabetes care | Chief Tech/Sci/R&D Officer | - |
Aventis Behring
 Aventis Behring Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Chief Tech/Sci/R&D Officer | - |
Novartis Pharmaceuticals UK Ltd.
 Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines and drugs | Corporate Officer/Principal | - |
Training of Michael Sumner
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
68
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Shire Regenerative Medicine, Inc.
Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Manufactures biomedical products | Health Technology |
Novartis Pharmaceuticals UK Ltd.
Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines and drugs | Health Technology |
Orexo AB
 Orexo AB Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products | Health Technology |
Aventis Behring
Aventis Behring Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inovio Pharmaceuticals, Inc.
 Inovio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic vaccines and immune therapies for cancers and infectious diseases | Health Technology |
Henley Management College
 Henley Management College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novo Nordisk Pharmaceuticals Pty Ltd.
Novo Nordisk Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for diabetes care | Health Technology |
- Stock Market
- Insiders
- Michael Sumner
